AMP opposes NIH proposal to license cancer-related proteonomics patent The Association for Molecular Pathology believes exclusive licensing of National Institutes of Health cancer discovery is contrary to the public interest The Association for Molecular Pathology opposed the National Institutes of Wellness proposal to exclusively license the subject matter of a cancer-related proteonomics patent application filed by the Company generic viagra . AMP’s written remarks had been submitted to NIH in response to a obtain comments in the Federal Register Notice entitled, ‘Potential Grant of Exclusive Permit: The Development of a Companion Diagnostic Package for Predicting Therapeutic Efficacy of Anti-Cancer Agents.’ The proposed license grants exclusive worldwide rights to use the relationships between degrees of three proteins, PTEN, Akt, and mTOR and cancers of the breast, lung, and kidney.

According to ANH, author Dr. Jaakko Mursu deliberately excluded lifestyle factors from their data equation, which ultimately skewed the results. Lifestyle factors play a hugely significant function in mortality rates, of course, but these details was omitted. The research team also admits in the ultimate comment part of its research that it failed to gather data about supplements taken within a specific medical regimen. The team says it did not have any data ‘concerning nutritional status or detailed information of health supplements used, ‘ which really is a significant insufficiency that proves the illegitimacy of the analysis.